The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Authors
Keywords
Organoids, Cancer treatment, Renal cancer, Lymphocytes, Cancers and neoplasms, T cells, Breast cancer, Ovarian cancer
Journal
PLoS One
Volume 15, Issue 7, Pages e0235705
Publisher
Public Library of Science (PLoS)
Online
2020-07-11
DOI
10.1371/journal.pone.0235705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells
- (2019) Parysatis Sachs et al. Nature Communications
- CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
- (2019) Yibo Xue et al. Nature Communications
- SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
- (2019) Yibo Xue et al. Nature Communications
- SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors
- (2019) Tatiana Shorstova et al. CANCER RESEARCH
- Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
- (2019) Tomoyuki Naito et al. Thoracic Cancer
- HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer.
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
- (2019) Amaury Leruste et al. CANCER CELL
- ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
- (2018) Joseph J. Caumanns et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
- (2018) Jessica D. Lang et al. CLINICAL CANCER RESEARCH
- Small cell cancers of the female genital tract: Molecular and clinical aspects
- (2018) Jay R. Patibandla et al. GYNECOLOGIC ONCOLOGY
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
- (2018) Jianfeng Shen et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications
- (2018) Rugang Zhang et al. MOLECULAR CANCER RESEARCH
- Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type
- (2018) Yemin Wang et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
- (2018) Ye Qin et al. ONCOGENE
- Author Correction: The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells
- (2018) Hiroaki Hiramatsu et al. Scientific Reports
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
- (2017) Yemin Wang et al. JOURNAL OF PATHOLOGY
- Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities
- (2017) Akihiko Yoshida et al. MODERN PATHOLOGY
- Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models
- (2017) Elayne Chan-Penebre et al. MOLECULAR CANCER THERAPEUTICS
- Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway
- (2017) S Ambrosio et al. ONCOGENE
- SMARCB1-deficient Tumors of Childhood: A Practical Guide
- (2017) Bruce R Pawel PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Composition and Function of Mutant Swi/Snf Complexes
- (2017) Arnob Dutta et al. Cell Reports
- The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells
- (2017) Hiroaki Hiramatsu et al. Scientific Reports
- SWI/SNF Complex–deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract
- (2016) Abbas Agaimy et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Hormone‐induced repression of genes requires BRG1‐mediated H1.2 deposition at target promoters
- (2016) Ana Silvina Nacht et al. EMBO JOURNAL
- Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology
- (2016) Preetha Ramalingam et al. HISTOPATHOLOGY
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- SWI/SNF Chromatin Remodeling and Human Malignancies
- (2015) Julien Masliah-Planchon et al. Annual Review of Pathology-Mechanisms of Disease
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis
- (2015) Peter M. Brownlee et al. DNA REPAIR
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
- (2015) Anthony N Karnezis et al. JOURNAL OF PATHOLOGY
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- SWI/SNF chromatin remodeling complexes and cancer
- (2014) Jaclyn A. Biegel et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
- (2014) Petar Jelinic et al. NATURE GENETICS
- Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
- (2014) G. R. Hoffman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
- (2014) S. Chen et al. Cancer Immunology Research
- The histone LSD1 demethylase in stemness and cancer transcription programs
- (2013) Stefano Amente et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
- (2013) T. Oike et al. CANCER RESEARCH
- High-Throughput Virtual Screening Identifies Novel N′-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors
- (2013) Venkataswamy Sorna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
- (2013) O. A. Romero et al. Cancer Discovery
- Nicotinic acetylcholine receptors mediate lung cancer growth
- (2013) Ma. Reina Improgo et al. Frontiers in Physiology
- Clear cell carcinoma of the ovary: A review of the literature
- (2012) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- NOTCH1 Nuclear Interactome Reveals Key Regulators of Its Transcriptional Activity and Oncogenic Function
- (2012) Ahmad Yatim et al. MOLECULAR CELL
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A
- (2011) Todd S. Macfarlan et al. GENES & DEVELOPMENT
- Silencing of endogenous retroviruses: when and why do histone marks predominate?
- (2011) Danny C. Leung et al. TRENDS IN BIOCHEMICAL SCIENCES
- Non-Coding RNAs in Neural Networks, REST-Assured
- (2011) Michael Rossbach Frontiers in Genetics
- Cross-talk between post-translational modifications regulates life or death decisions by E2F1
- (2010) Haroula Kontaki et al. CELL CYCLE
- Histone lysine demethylases function as co-repressors of SWI/SNF remodeling activities during Drosophila wing development
- (2010) Brenda J. Curtis et al. DEVELOPMENTAL BIOLOGY
- Lysine Methylation Regulates E2F1-Induced Cell Death
- (2010) Haroula Kontaki et al. MOLECULAR CELL
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
- (2009) J. H. Schulte et al. CANCER RESEARCH
- Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements
- (2009) Sebastian Szpakowski et al. GENE
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
- (2008) Jing Wang et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now